Patent Law Weblog
recent posts
- Retired Judges File Amicus Brief in Support of Judge Newman
- Hikma v. Amarin at the Supreme Court: The Parties’ Opening Briefs
- Teva Pharmaceuticals International v. Eli Lilly & Co. (Fed. Cir. 2026)
- USPTO Extends Artificial Intelligence Search Automated Pilot Program (ASAP!)
- USPTO Announces That It Has Turned the Corner on Unexamined Application Backlog
about
Month: October 2015
-
D'Arcy v. Myriad Genetics Inc & Anor [2015] HCA 35 By Claire Gregg & Martin O'Brien — The High Court of Australia today handed down its decision in D'Arcy v Myriad, deciding once and for all that isolated nucleic acids do not define patent-eligible subject matter in Australia. Following a five-judge unanimous decision of the…
-
D'Arcy v Myriad Genetics Inc [2015] HCA 35 By Bindhu Holavanahalli* and Gary Cox** — The High Court of Australia has today handed down its decision in D'Arcy v Myriad Genetics Inc [2015] HCA 35, unanimously striking down the validity of the first three claims of Myriad Genetics Inc's (Myriad) patent. Those claims related to…
-
By Kevin E. Noonan — More than three years after the June 15, 2012 deadline for providing it, the U.S. Patent and Trademark Office has issued its report on so-called "second opinion" genetic diagnostic testing, mandated by Section 27 of the Leahy-Smith America Invents Act. With (evidently in the eyes of Patent Office officials) the…
-
Swearing Behind Reference Still Requires Proof of (Timely Filed) Evidence By Joseph Herndon — Thomas Steed, Sourav Bhattacharya, and Sandeep Seshadrijois (collectively "Steed") filed a patent application entitled "Web-Integrated On-Line Financial Database System and Method for Debt Recovery," on April 6, 2004, with priority claimed to a provisional application filed on November 13, 2003. The…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. United Therapeutics Corp. v. Watson Laboratories, Inc.3:15-cv-05723; filed July 22, 2015 in the District Court of New Jersey Infringement of U.S. Patent Nos. 6,521,212 ("Method for Treating Peripheral Vascular Disease By Administering Benzindene Prostaglandins…
-
October 5, 2015 – "Amgen v. Sandoz: Federal Circuit Interprets 'Patent Dance' Provisions of BPCIA to Permit Biosimilar Applicant to Refuse to Disclose Application and Manufacturing Information" (Practising Law Institute) – 1:00 to 2:00 pm (Eastern) October 6, 2015 – "USPTO's Proposed Changes to PTAB Practice: A Primer on the Recently Proposed Amendments to the…
-
Practising Law Institute (PLI) will be offering a one-hour webcast entitled "Amgen v. Sandoz: Federal Circuit Interprets 'Patent Dance' Provisions of BPCIA to Permit Biosimilar Applicant to Refuse to Disclose Application and Manufacturing Information" on October 5, 2015 from 1:00 to 2:00 pm (Eastern). Patent Docs author Kevin E. Noonan, Ph.D. of McDonnell Boehnen Hulbert…
-
The Intellectual Property Owners Association (IPO) will offer a one-hour webinar entitled "Definite Change: Nautilus Gets Some Traction" on October 7, 2015 from 2:00 to 3:00 pm (ET). Robert Kramer of Dentons US LLP, Chris Mammen of Hogan Lovells, and Bryan Zielinski of Pfizer Inc. will analyze several recent Federal Circuit opinions that cite Nautilus…
-
The George Washington Law School will be holding a Post-Grant Practice Roundtable Discussion on October 13, 2015 at the George Washington University Law School. The half-day program will explore current issues with U.S. post-grant review from two perspectives: first, the post-grant practice at the PTAB and second, how the development of post-grant procedures has affected…
-
McDonnell Boehnen Hulbert & Berghoff LLP will be offering a live webinar on "Trust Everybody, but Cut the Cards" on October 20, 2015 from 10:00 am to 11:15 am (CT). In this presentation, MBHB attorneys Grantland G. Drutchas and James L. Lovsin will discuss confidentiality agreements and confidentiality provisions and the risks and unintended consequences…
Patent Docs 